What is JUNS's dilution risk score?

JUNS has a latest available DilutionScore record of 60/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for JUNS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for JUNS?

DilutionWatch tracks 25 SEC filing types for JUNS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect JUNS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For JUNS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for JUNS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for JUNS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

JUNS Dilution Risk Score: 60/100 (HIGH)

Score Breakdown

📋 Offering Ability

90

💰 Cash Runway

40

📊 Float Risk

7

⚠️ Warrant Exposure

50

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 36%

🔄 Reverse Split model est. 55%

• 50-day avg $0.36 below $1 exchange minimum

💰 Capital Raise model 20%

• Active shelf registration ($100M, 900% of market cap)

📜 Warrant Exercise model 15%

• Warrant overhang: 14.2% of shares outstanding

🔔 Track JUNS — Get forecast alerts →

Market Data

Market Cap$11.12M

Shares Outstanding36.28M

Float16.59M

Cash$3.79M

Debt$5.32M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 254.4% shares (2026Q1 vs prior)

10 institutional holders · 2.26M shares

#1 VESTOR CAPITAL, LLC 971.0K shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 719.8K shares

#3 GEODE CAPITAL MANAGEMENT, LLC 211.7K shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest205.2K

Days to Cover1.0

% of Float1.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2025-06-22

EFFECT EFFECT 2026-04-24

S-3 SHELF 2026-04-16

8-K 8K EVENT 2026-02-20

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual JUNS Dilution Snapshot

Jupiter Neurosciences, Inc. (JUNS) has a DilutionScore of 60/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $100.0M.
Stored outstanding warrants: 109,376.
Recent SEC activity tracked for JUNS: xbrl on 2026-06-30; EFFECT on 2026-04-24; S-3 on 2026-04-16.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.